MedTrace Logo

Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy

NCT03444116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2021-02-10

No results posted yet for this study

Summary

Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families by providing families the information needed to make the most informed decision possible about this aspect of their child's healthcare.

Conditions

  • Cerebral Palsy
  • Femoral Derotation Osteotomy
  • Outcomes

Interventions

DIAGNOSTIC_TEST

Motion Analysis

Gait and Motion Analysis, comprised of 3-dimensional kinematics and kinetics, electromyography, energy expenditure, and physical exam (range of motion, strength, spasticity, etc.)

DIAGNOSTIC_TEST

sterEOS Imaging of Lower Extremities

Bi-planar imaging of the lower extremities to evaluate femoral anteversion and hip dysplasia and subluxation.

BEHAVIORAL

Surveys

9 surveys assessing function, activity, participation, pain, quality of life, and treatment history.

Sponsors & Collaborators

  • Gillette Children's Specialty Healthcare

    lead OTHER

Principal Investigators

  • Tom F Novacheck, MD · Gillette Children's Specialty Healthcare

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-12
Primary Completion
2019-11-15
Completion
2019-11-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444116 on ClinicalTrials.gov